Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

被引:4
|
作者
Xiao, Xiangyuqin [1 ]
Wu, Yaqin [1 ]
Zou, Lianhong [2 ]
Chen, Yiru [1 ]
Zhang, Chaojie [1 ]
机构
[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Affiliated Hosp 1, Dept Breast & Thyroid Surg, Changsha 410005, Peoples R China
[2] Hunan Normal Univ, Hunan Prov Peoples Hosp, Affiliated Hosp 1, Inst Translat Med, Changsha, Peoples R China
关键词
Papillary thyroid carcinoma (PTC); lymph nodes posterior to the right recurrent laryngeal nerve (LN-prRLN); central compartment lymph node dissection; risk factor; RISK-FACTORS; METASTASIS; CANCER;
D O I
10.21037/gs-22-337
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Tumor metastasis to lymph nodes posterior to the right recurrent laryngeal nerve (LN-prRLN) is a main cause of disease recurrence in patients with papillary thyroid carcinoma (PTC), which may increase the risk of recurrence and secondary surgery, and the disruption of normal anatomical relationships during secondary surgery increases the risk of laryngeal nerve injury and hypoparathyroidism. However, controversy remains as to whether the dissection of LN-prRLN is required in cN(0) PTC patients. The purpose of this study is to explore the factors associated with LN-prRLN metastasis in patients with cN(0) PTC and the need for LN-prRLN node dissection in patients with cN(0) PTC who undergo right central compartment dissection. Methods: The clinical data of 290 patients with cN0 PTC who received radical thyroid cancer surgery from December 2019 to March 2022 at our center were retrospectively analyzed. All the patients underwent thyroid lobectomy and right central lymph node dissection (CLND), along with other treatments. SPSS 26.0 statistical software was used for the analysis. The measurement data were compared using the rank-sum test, and the count data were compared using the chi-square test. Results: LN-prRLN metastasis was detected in 65 (22.4%) of the 290 cN0 PTC patients. The metastasis sites included level VIa (51.72%), the left central compartment (22.76%), and the prelaryngeal compartment (8.97%). The univariate analysis revealed that tumor multifocality, a tumor diameter >1 cm, capsular invasion, LN metastasis in the left central compartment, and level VIa positivity were influencing factors of LN-prRLN metastasis in PTC patients. The logistic regression analysis showed that a tumor diameter >1 cm (OR =2.897, 95% CI: 1.630-5.147, P<0.001), LN metastasis in the left central compartment (OR =3.724, 95% CI: 2.039-6.801, P<0.001), and level VIa (OR =3.405, 95% CI: 1.846-6.281, P<0.001) positivity were independent risk factors of LN-prRLN metastasis in PTC patients. Conclusions: The high-risk factors of LN-prRLN metastasis in cN(0) PTC patients include a large tumor (a diameter >1 cm), lymph node metastasis in the left central compartment, and lymph node metastasis in level VIa. For patients with cN(0) PTC undergoing right CLND, with high-risk factors of LN-prRLN metastasis, LN-prRLN dissection is recommended.
引用
收藏
页码:1204 / 1211
页数:8
相关论文
共 50 条
  • [1] Preoperative Prediction of Metastatic Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in cN0 Papillary Thyroid Carcinoma
    Shao, Jun
    Wang, Xiya
    Yu, Haiyuan
    Ding, Wei
    Xu, Bin
    Ma, Dongsheng
    Huang, Xuechun
    Yin, Hongqing
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 421 - 429
  • [2] Metastasis of cN0 Papillary Thyroid Carcinoma of the Isthmus to the Lymph Node Posterior to the Right Recurrent Laryngeal Nerve
    Du, Wei
    Fang, Qigen
    Zhang, Xu
    Dai, Liyuan
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [3] Clinical value and indication for the dissection of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma
    Luo, Ding-Cun
    Xu, Xiao-Cheng
    Ding, Jin-Wang
    Zhang, Yu
    Peng, You
    Pan, Gang
    Zhang, Wo
    ONCOTARGET, 2017, 8 (45) : 79897 - 79905
  • [4] Carbon nanoparticle-guided intraoperative lymph node biopsy predicts the status of lymph nodes posterior to right recurrent laryngeal nerve in cN0 papillary thyroid carcinoma
    Ling, Yuwei
    Zhang, Lina
    Li, Kaifu
    Zhao, Ye
    Zhao, Jing
    Jia, Luyao
    Wang, Yajun
    Kang, Hua
    GLAND SURGERY, 2021, 10 (05) : 1554 - 1563
  • [5] Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma
    Jianzhong Hou
    Haojie Shan
    Yingchao Zhang
    Youben Fan
    Bo Wu
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 881 - 886
  • [6] Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma
    Hou, Jianzhong
    Shan, Haojie
    Zhang, Yingchao
    Fan, Youben
    Wu, Bo
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (03) : 881 - 886
  • [7] Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe
    Zhang, Songtao
    Zhang, Runfang
    Wang, Chao
    Gong, Wenbo
    Zheng, Chen
    Fang, Qigen
    Dai, Liyuan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma A retrospective study
    Yuan, Jiru
    Li, Jinghua
    Chen, Xiaoyi
    Zhong, Zhenwei
    Chen, Zhengbo
    Yin, Ying
    Du, Jialin
    Cong, Shuzhen
    Wu, Zeyu
    MEDICINE, 2017, 96 (35)
  • [9] Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma
    Zhou, Mengqian
    Duan, Yuansheng
    Ye, Beibei
    Wang, Yuxuan
    Li, Hong
    Wu, Yue
    Chen, Peng
    Zhu, Jiajia
    Jing, Chao
    Wu, Yansheng
    Wang, Xudong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Individualized Prediction Of Metastatic Involvement Of Lymph Nodes Posterior To The Right Recurrent Laryngeal Nerve In Papillary Thyroid Carcinoma
    Zhu, Jiang
    Huang, Rui
    Xu, DaiXing
    Dou, Yi
    Ren, HaoYu
    Yang, ZhiXin
    Deng, Chang
    Xiong, Wei
    Wang, Denghui
    Mao, Yu
    Li, Xuesong
    Su, XinLiang
    ONCOTARGETS AND THERAPY, 2019, 12 : 9077 - 9084